Hubid, Rolly .
HRN: 12-34-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
CEFTRIAXONE 1G (VIAL)
07/25/2024
07/27/2024
IVT
2g
OD
TYphoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes